|
|
|
|
|
|
Complexity of Gold(Ⅲ) Ion With Cefotaxime and Cefepime Drugs: Spectroscopic, Antimicrobial and Antitumor Discussions |
Lamia A Albedair1*, Samar O Aljazzar1, Mohamed I Kobeasy2,3,Moamen S Refat3,4* |
1. College of Science, Princess Nourah bint Abdulrahman University, Department of Chemistry, Saudi Arabia
2. Department of Biochemistry, Faculty of Agriculture, Cairo University, Giza, Egypt
3. Department of Chemistry, Faculty of Science, Taif University, Al-Hawiah, Taif 21974, Saudi Arabia
4. Department of Chemistry, Faculty of Science, Port Said University, Port Said, Egypt |
|
|
Abstract The availability of chemical and biological data presented in this paper is the basis for understanding not only the current state of anti-cancer drugs based on gold(Ⅲ), but also the rationale for strategies for future drug design. New Au(Ⅲ) nanosized complexes of cefotaxime (ceph-3) and cefepime (ceph-4) ligands as a 3rd and 4th of cephalosporin generation drugs were synthesized. Gold(Ⅲ) complexes were discussed based on the elemental, molar conductance, thermal and magnetic moment measurements as well as spectral (FTIR, 1HNMR, UV-Vis, and XRD) techniques. FT-IR spectra revealed that the ceph-3 and ceph-4 ligands reacted as a bidentate ligands through carboxylate oxygen and β-lactam oxygen groups. The analytical analysis confirm that the molar ratio is 1∶1 (Au3+/ceph) with general formula [Au(L)(Cl)2] where L=ceph-3 or ceph-4. The structures of Au(Ⅲ) complexes were presence as a square planar geometry. X-ray diffraction patterns referred to a crystalline nature for all synthesized complexes. TEM analyses confirmed that the synthetic gold(Ⅲ) complexes have a nanosized particles. In vitro antimicrobial activities of Au(Ⅲ) complexes were evaluated towards two types of bacteria (G+ & G-). The antitumor activities of gold(Ⅲ) complexes are appraised against breast (MCF-7) and colorectal adenocarcinoma (Caco-2) cell lines, which means that the two complexes may consider promising anticancer drugs.
|
Received: 2020-02-25
Accepted: 2020-06-17
|
|
Corresponding Authors:
Lamia A Albedair,Moamen S Refat
E-mail: msrefat@yahoo.com
|
|
[1] Parfitt K. “Martindale” The Complete Drug Reference. 33nd Edition. The Pharmaceutical Press, London, 2002. 167.
[2] Anacona J R, Rodriguez A. Trans. Met. Chem., 2005, 30: 897.
[3] Bergan T. Drugs, 1987, 34: 89.
[4] Ribeiro A R, Sures B, Schmidt T C. Environmental Pollution, 2018, 241: 1153.
[5] García-Estrada C, Martín J F. Comprehensive Biotechnology. Third Edition, Volume 3, 2019. 283.
[6] Sunjaya D B, Lennon R J, Shah V H, et al. Mayo Clinic Proceedings, 2019,94(8):1499.
[7] Anacona J R, Da Silva G. J. Chil. Chem. Soc., 2005, 50(2): 447.
[8] Okamoto M P, Nakahiro R K, Chin A, et al. Am. J. Hosp. Pharm., 1994,51(4):463.
[9] Barradell L B, Bryson H M. Drugs, 1994,47(3):471.
[10] Cunha B A, Gill M V. Med. Clin North Am., 1995, 79(4): 721.
[11] Chapman T M, Perry C M. Am. J. Respir Med., 2003, 2(1): 75.
[12] Anacona J R, Rodriguez H. J. Coord Chem., 2009, 62(13): 2212.
[13] Page S. Educ Chem., 2012, 10: 26.
[14] Farrell N. Drugs Chemother Agents., 1989, 11: 809.
[15] Ndagi U, Mhlongo N, Soliman M E. Drug. Des. Devel. Ther., 2017, 11: 599.
[16] Wheate N J, Walker S, Craig G E, et al. Dalton Trans., 2012, 39(35): 8113.
[17] El-Habeeb A A, Refat M S. J. Mol. Struct., 2019, 1175: 65.
[18] El-Megharbel S M, Hamza R Z, Gobouri A A, et al. Appl. Organomet. Chem., 2019,e4892:1.
[19] Naglah A M, Al-Omar M A, Kalmouch A, et al. Future Med. Chem., 2019,11(3):193.
[20] Naglah A M, Refat M S, AlOmar M A, et al. Drug Design, Development and Therapy, 2019,13:1409.
[21] El-Habeeb A A, Refat M S. Spectroscopy and Spectral Analysis, 2019,39(9):2982.
[22] Bauer A W, Kirby W A, Sherris C, et al. Am. J. Clin. Pathology, 1996,45:493.
[23] Pfaller M A, Burmeister L, Bartlett M A, et al. J. Clin. Microbiol., 1988,26:1437.
[24] Repetto G, del Peso A, Zurita J L. Nature Protocols, 2008, 3(7): 1125.
[25] Anaconaa J R, Rodriguez J R. J. Coord. Chem., 2004,57:1263.
[26] Anacona J R, Alvarez P. Trans. Met. Chem., 2002, 27: 856.
[27] Z Hong-Yum, C Dong-Li, C Pei-Kun, et al. Polyhedron, 1992,11:2313.
[28] Anacona J R, Da Silva G. J. Chil. Chem. Soc., 2005,50(2):447.
[29] Lever A B P. Inorganic Electronic Spectroscopy, 2nd ed. Amsterdam; New York: Elsevier; 1984. 863.
[30] Altun Ö, Şuözer M. JOTCSA., 2017, 4(sp. is. 1): 1.
[31] Patterson A L. Phys. Rev., 1939, 56: 978.
[32] Shungu D L. J. Clin. Microbiol., 1988, 18: 888.
[33] Shungu D L. Antimicrob. Agents Chemother, 1983, 23: 256. |
[1] |
Samar O. Aljazzar. Spectroscopic Characterizations of Metal-Complexes of 4-Hydroxybenzoic Acid With the Ni(Ⅱ), Mn(Ⅱ), and Cu(Ⅱ) Ions[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2021, 41(06): 1971-1975. |
[2] |
Ahmed. I. El-Shenawy*, Ishaq. F. E. Ahmed, Moamen. S. Refat. Fabrication of Semiconductor Polymer Membranes Combined with a Colored Charge Transfer Complexes Used in the Manufacture of Solar Cells as a Source of Alternative Energy[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2019, 39(07): 2307-2315. |
[3] |
Sibel Morkoç Karadeniz1*, Tuba Klnç1, Burcu Bozkurt rak2, Tuba Irmak Sakaolu1, ar rak1, Mehmet Erturul3, Ali Ercan Ekinci1. Structural, Morphological and Optical Properties of Well-Ordered CdO Nanostructures Synthesized by Easy-Economical Chemical Bath Deposition Technique[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2016, 36(06): 1998-2000. |
[4] |
ZHANG Hao1, WANG Peng-jie2, LEI Xin-gen3, YANG Hong-ju4, ZHANG Lu-da2, REN Fa-zheng2, ZHENG Li-min1* . Spectroscopic Evaluation of Effects of Heat Treatments on the Structures and Emulsifying Properties of Caseins [J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2013, 33(05): 1275-1280. |
[5] |
WANG Fang1, LIU Ai-ping1, REN Fa-zheng1, ZHANG Xiao-ying1,2, Stephanie Clark3, ZHANG Lu-da4, GUO Hui-yuan1* . FTIR Analysis of Protein Secondary Structure in Cheddar Cheese during Ripening[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2011, 31(07): 1786-1789. |
[6] |
FENG Chang-gen1, XIONG Yu-di1, LIU Xia2 . Synthesis, Spectroscopy and Antibacterial Activity of Supermolecular Compounds of Organotitanium Substituted Heteropolytungstates Containing 8-Quinolinol[J]. SPECTROSCOPY AND SPECTRAL ANALYSIS, 2011, 31(05): 1153-1160. |
|
|
|
|